Efficacy and safety of subcutaneous and intravenous rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in first-line diffuse large B-cell lymphoma: the randomized MabEase study

皮下和静脉注射利妥昔单抗联合环磷酰胺、阿霉素、长春新碱和泼尼松治疗一线弥漫大 B 细胞淋巴瘤的疗效和安全性：随机 MabEase 研究